InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the complete record of transactions filed by Hindson Benjamin J., Autre. Insider active across 1 companies, notably 10x Genomics, Inc.. In total, 29 disclosures have been published. Total volume traded: €268k. The latest transaction was disclosed on 23 May 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations29 total
€57,7021,264 shares@ €45.650.0028% mcap3.9% of flow
Class A Common Stock
SEC:0001567619-22-011712:0·
028,476 shares0
Class A Common Stock
SEC:0001567619-22-007442:0·
€25,018360 shares@ €69.49320.0012% mcap1.7% of flow
Class A Common Stock
SEC:0001567619-22-005522:0·
€21,0352,084 shares@ €10.09370.0010% mcap3.0% of flow
Class A Common Stock
SEC:0001567619-22-000621·
€21,0352,084 shares@ €10.09370.0010% mcap1.4% of flow
Class A Common Stock
SEC:0001567619-22-000621:0·
€50,95253,952 shares@ €0.94440.0024% mcap7.3% of flow
Class A Common Stock
SEC:0001567619-21-022724·
€50,95253,952 shares@ €0.94440.0024% mcap3.4% of flow
Class A Common Stock
SEC:0001567619-21-022724:0·
€16,2183,646 shares@ €4.44830.0008% mcap2.3% of flow
Class A Common Stock
SEC:0001567619-21-021615·
€16,2183,646 shares@ €4.44830.0008% mcap1.1% of flow
Class A Common Stock
SEC:0001567619-21-021615:0·
€46,189351 shares@ €131.59330.0022% mcap6.6% of flow
Class A Common Stock
SEC:0001567619-21-021187·
€46,189351 shares@ €131.59330.0022% mcap3.1% of flow
Class A Common Stock
SEC:0001567619-21-021187:0·
€44,62310,232 shares@ €4.36110.0021% mcap6.4% of flow
Class A Common Stock
SEC:0001567619-21-019297·
€44,62310,232 shares@ €4.36110.0021% mcap3.0% of flow
Class A Common Stock
SEC:0001567619-21-019297:0·
€181,43141,666 shares@ €4.35440.0087% mcap25.9% of flow
Class A Common Stock
SEC:0001567619-21-017948·
€181,43141,666 shares@ €4.35440.0087% mcap12.2% of flow
Class A Common Stock
SEC:0001567619-21-017948:0·
€177,34841,666 shares@ €4.25640.0085% mcap25.3% of flow
Class A Common Stock
SEC:0001209191-21-054899·
€177,34841,666 shares@ €4.25640.0085% mcap12.0% of flow
Class A Common Stock
SEC:0001209191-21-054899:0·
€46,441337 shares@ €137.80670.0022% mcap6.6% of flow
Class A Common Stock
SEC:0001209191-21-053391·
€46,441337 shares@ €137.80670.0022% mcap3.1% of flow
Class A Common Stock
SEC:0001209191-21-053391:0·
€11,23111,114 shares@ €1.01060.0005% mcap1.6% of flow
Class A Common Stock
SEC:0001209191-21-049643·
€11,23111,114 shares@ €1.01060.0005% mcap0.8% of flow
Class A Common Stock
SEC:0001209191-21-049643:0·
€42,20741,666 shares@ €1.0130.0020% mcap6.0% of flow
Class A Common Stock
SEC:0001209191-21-045469·
€42,20741,666 shares@ €1.0130.0020% mcap2.8% of flow
Class A Common Stock
SEC:0001209191-21-045469:0·
€40,92341,666 shares@ €0.98220.0020% mcap5.8% of flow
Class A Common Stock
SEC:0001209191-21-037900·
€40,92341,666 shares@ €0.98220.0020% mcap2.8% of flow
Class A Common Stock
SEC:0001209191-21-037900:0·
25 of 29 declarations
About Hindson Benjamin J.
Benjamin J. Hindson is an executive at 10x Genomics, Inc.
